Oakridge International Limited (ASX:OAK): Could This Healthcare Technology Company Be Quietly Building Momentum?

Sonal Goyal

10 July 2026 11:40 AM AEST

Oakridge International Limited (ASX:OAK): Could This Healthcare Technology Company Be Quietly Building Momentum?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key takeaways

Oakridge International develops and distributes nurse call hardware and software solutions for hospitals, aged care, disability care and supported independent living facilities, alongside Internet of Things and geothermal projects.
The stock carries a reported price-to-earnings ratio of 11.27, and 07K shares with 45.
Investors may watch for continued revenue growth, new healthcare facility contracts and updates across its technology, healthcare and geothermal business segments.

Oakridge International Limited (ASX:OAK) is an Adelaide-based healthcare technology and Internet of Things company developing and distributing nurse call hardware and software solutions for hospitals, aged care, disability care and supported independent living facilities, with additional operations across geothermal projects.

Oakridge International operates across four segments: technology development, healthcare technology, geothermal projects and corporate.

Potential catalysts investors may monitor

Several developments could be relevant to Oakridge International's share price over time.

Continued revenue growth across its healthcare technology and nurse call systems business
New contracts with hospitals, aged care or disability care providers for its nurse call solutions
Progress or updates on the company's geothermal projects segment
Further improvement in profitability, building on the reported reduction in losses
Broader adoption of Internet of Things technology within the healthcare facilities sector

Financial position and funding considerations

27, consistent with

The company reported FY2025 revenue of 18 million a year earlier, alongside losses of A$128,795, a reduction of 83.08% compared with the prior year.

While these figures point to improving financial performance, investors should review the full audited financial statements for further detail on cash flow, segment performance and any funding requirements.

Industry and sector backdrop

Healthcare technology, including nurse call and patient monitoring systems, continues to see steady demand as hospitals, aged care and disability care providers look to modernise facility infrastructure.

The broader Internet of Things sector has also expanded within healthcare settings, supporting connected devices and data-driven facility management.

Smaller companies in this space, such as Oakridge International, typically compete for contracts against both established medical technology suppliers and other niche providers.

Material risks

Investors considering Oakridge International should weigh a number of risks typical of small, diversified technology companies.

Reliance on a relatively small number of healthcare facility contracts for revenue
Execution risk in maintaining the pace of revenue growth reported in FY2025
Diversification into geothermal projects, which represents a different risk profile to its core healthcare technology business
Competitive pressure from larger medical technology and IoT providers
Low market capitalisation and share price, which can contribute to volatility despite improving financial metrics

What investors may watch next

Investors may watch for the company's next financial reporting period to assess whether the strong FY2025 revenue growth has continued.

New contract announcements with healthcare facilities, along with any updates on the geothermal projects segment, would also be relevant.

Outlook for Oakridge International shares

The outlook for Oakridge International will likely depend on whether the company can sustain the strong revenue growth and reduced losses reported in FY2025.

A positive scenario could see continued contract wins and margin improvement support further re-rating of the stock relative to its small market capitalisation.

A more cautious scenario could involve a slowdown in growth or renewed losses, and neither outcome should be assumed as a certainty.

Conclusion

Oakridge International Limited stands out among ASX micro-caps for its reported revenue growth and narrowing losses in the healthcare technology and Internet of Things space.

071 and a 27M

FAQs

Q: What does Oakridge International Limited (ASX: OAK) do?

A: Oakridge International develops and distributes nurse call hardware and software solutions for healthcare facilities, alongside Internet of Things technology and geothermal projects.

Q: How much revenue did Oakridge International report in FY2025?

A: 43 million, an increase of 106.74% compared with million in the prior year.

Q: What business segments does Oakridge International operate?

A: The company operates across four segments: technology development, healthcare technology, geothermal projects and corporate.

Q: What are the main risks for Oakridge International shareholders?

A: Key risks include reliance on a limited number of healthcare contracts, execution risk in sustaining growth, diversification into geothermal projects and competitive pressure from larger technology providers.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.